Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece

S. Avgeris, F. Fostira, A. Vagena, Y. Ninios, A. Delimitsou, R. Vodicka, R. Vrtel, S. Youroukos, DJ. Stravopodis, M. Vlassi, A. Astrinidis, D. Yannoukakos, GE. Voutsinas,

. 2017 ; 7 (1) : 16697. [pub] 20171201

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035501

Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder causing benign tumors in the brain and other vital organs. The genes implicated in disease development are TSC1 and TSC2. Here, we have performed mutational analysis followed by a genotype-phenotype correlation study based on the clinical characteristics of the affected individuals. Twenty unrelated probands or families from Greece have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagnosis. Using direct sequencing, we have identified pathogenic mutations in 13 patients/families (6 in TSC1 and 7 in TSC2), 5 of which were novel. The mutation identification rate for patients with definite TSC was 85%, but only 29% for the ones with a possible TSC diagnosis. Multiplex ligation-dependent probe amplification (MLPA) did not reveal any genomic rearrangements in TSC1 and TSC2 in the samples with no mutations identified. In general, TSC2 disease was more severe than TSC1, with more subependymal giant cell astrocytomas and angiomyolipomas, higher incidence of pharmacoresistant epileptic seizures, and more severe neuropsychiatric disorders. To our knowledge, this is the first comprehensive TSC1 and TSC2 mutational analysis carried out in TSC patients in Greece.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035501
003      
CZ-PrNML
005      
20191008113036.0
007      
ta
008      
191007s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-017-16988-w $2 doi
035    __
$a (PubMed)29196670
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Avgeris, Socratis $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
245    10
$a Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece / $c S. Avgeris, F. Fostira, A. Vagena, Y. Ninios, A. Delimitsou, R. Vodicka, R. Vrtel, S. Youroukos, DJ. Stravopodis, M. Vlassi, A. Astrinidis, D. Yannoukakos, GE. Voutsinas,
520    9_
$a Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder causing benign tumors in the brain and other vital organs. The genes implicated in disease development are TSC1 and TSC2. Here, we have performed mutational analysis followed by a genotype-phenotype correlation study based on the clinical characteristics of the affected individuals. Twenty unrelated probands or families from Greece have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagnosis. Using direct sequencing, we have identified pathogenic mutations in 13 patients/families (6 in TSC1 and 7 in TSC2), 5 of which were novel. The mutation identification rate for patients with definite TSC was 85%, but only 29% for the ones with a possible TSC diagnosis. Multiplex ligation-dependent probe amplification (MLPA) did not reveal any genomic rearrangements in TSC1 and TSC2 in the samples with no mutations identified. In general, TSC2 disease was more severe than TSC1, with more subependymal giant cell astrocytomas and angiomyolipomas, higher incidence of pharmacoresistant epileptic seizures, and more severe neuropsychiatric disorders. To our knowledge, this is the first comprehensive TSC1 and TSC2 mutational analysis carried out in TSC patients in Greece.
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a exony $7 D005091
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a delece genu $7 D017353
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a missense mutace $7 D020125
650    _2
$a rodokmen $7 D010375
650    _2
$a terciární struktura proteinů $7 D017434
650    _2
$a tuberózní skleróza $x genetika $x patologie $7 D014402
650    _2
$a hamartin $x genetika $7 D000077004
650    _2
$a tuberin $x genetika $7 D000077005
651    _2
$a Řecko $7 D006115
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fostira, Florentia $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Vagena, Andromachi $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Ninios, Yiannis $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Delimitsou, Angeliki $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Vodicka, Radek $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Vrtel, Radek $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Youroukos, Sotirios $u First Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Athens, Greece.
700    1_
$a Stravopodis, Dimitrios J $u Section of Cell Biology and Biophysics, Department of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, Athens, Greece.
700    1_
$a Vlassi, Metaxia $u Laboratory of Protein Structure and Molecular Modelling, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Astrinidis, Aristotelis $u Division of Nephrology, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center; Tuberous Sclerosis Complex Center of Excellence, Le Bonheur Children's Hospital; and Children's Foundation Research Institute, Memphis TN 38103, Tennessee, USA.
700    1_
$a Yannoukakos, Drakoulis $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Voutsinas, Gerassimos E $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. mvoutsin@bio.demokritos.gr.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 16697
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29196670 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008113452 $b ABA008
999    __
$a ok $b bmc $g 1452161 $s 1074051
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c 1 $d 16697 $e 20171201 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...